Lansap in treatment of esophagitis in patients with systemic sclerosis
Objective. To study the efficacy of Lansap (Lansoprasole) in treatment of esophagitis in pts with systemic sclerosis (SS). Methods. 30 SS pts with clinical manifestations and endoscopic signs of esophagitis received lansap 30 or 60 mg/day during two weeks. All pts had a standard endoscopic examinati...
Saved in:
Main Authors: | R T Alekperov, A E Karateev, N G Guseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2003-04-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/901 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radionuclide Diagnosis of Esophageal Dysmotility and Gastroesophageal Reflux in Patients with Systemic Sclerosis
by: R. A. Bashirov, et al.
Published: (2023-08-01) -
Esophagectomy for esophageal stricture with systemic sclerosis: a case report
by: Yuho Ebata, et al.
Published: (2023-11-01) -
Intravenous immunoglobulin for intensive therapy of fibrosing alveolitis in a patient TOC \o "1-5" \h \z with systemic sclerosis
by: R T Alekperov, et al.
Published: (2004-02-01) -
Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01) -
Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis
by: E. S. Kuvardin, et al.
Published: (2022-11-01)